Logo image
What the Baby Formula and Medical Contrast Material Shortages Have in Common: Insights and Recommendations for Managing the Iodinated Contrast Media Shortage
Journal article   Peer reviewed

What the Baby Formula and Medical Contrast Material Shortages Have in Common: Insights and Recommendations for Managing the Iodinated Contrast Media Shortage

Lakshmi Ananthakrishnan, Fernando U. Kay, Eric A. Zeikus, Eugene S. Chu, Joseph Chang, John D. Barr, Neil M. Rofsky and Suhny Abbara
Radiology. Cardiothoracic imaging, Vol.4(3), pp.e220101-e220101
06/01/2022
DOI: 10.1148/ryct.220101
PMCID: PMC9274312
PMID: 35833167
url
https://www.ncbi.nlm.nih.gov/pmc/articles/9274312View
Open Access

Abstract

The impact of supply chain and supply chain logistics, including personnel directly and indirectly related to the movement of supplies, has come to light in a variety of industries since the global COVID-19 pandemic. Acutely, the experience with baby formula and iodinated contrast material exposes key vulnerabilities to supply chains. The rather sudden diminished availability of iodinated contrast material has forced health care systems to engage in more judicious use of product through catalyzing the adoption of behaviors that had been recommended and deemed reasonable prior to the shortage. The authors describe efforts at a large, academic safety net county health system to conserve iodinated contrast media by optimizing contrast media use in the CT department and changing ordering patterns of referring providers. Special attention is given to opportunities to conserve contrast material in cardiothoracic imaging, including low kV and dual-energy CT techniques. A values-based leadership philosophy and collaboration with key stakeholders facilitate effective response to the critical shortage and rapid deployment of iodinated contrast media conservation strategies. Last, while the single-supplier model is efficient and cost-effective, its application to critically necessary services such as health care must be questioned considering disruptions related to the COVID-19 pandemic.
Life Sciences & Biomedicine Radiology, Nuclear Medicine & Medical Imaging Science & Technology

Details

Metrics

Logo image